LONDON, Feb. 20, 2018 /PRNewswire/ -- Prescient Healthcare Group, a global product strategy and decision support consultancy, announces the recent appointment of Dr. Debasish Talukdar as Global Head of Advisory.
Debasish joins Prescient after spending the last decade with Bain & Company, where he was a leader in the healthcare practice. Debasish has extensive experience advising biopharma clients on value creation through corporate, business unit, disease area and product-focused strategies. He started his career as a physician before making the move into strategy consulting, and he has lived and worked in the US, EU, India and Singapore. He holds an MBA from the Indian Institute of Management Calcutta, and has worked for the consumer goods company P&G.
"I'm excited to have joined Prescient and see huge opportunity to grow VantageRx, our advisory services business. We have an incredible team that offers a differentiated level of service to our clients through in-depth technical, therapeutic and market expertise," Debasish said. "We believe that all clinical and commercial strategies must be grounded in evidence and tested objectively. For a brand to achieve an optimal label, favorable reimbursement status and rapid uptake, our clients must be able to demonstrate superior clinical and health economic benefits to the standard of care. VantageRx focuses on identifying and deploying these critical value-generating levers."
"Debasish will be responsible for driving the future trajectory of our advisory practice," said Jamie Denison-Pender, CEO, Prescient. "His Tier 1 consultancy experience coupled with his medical background makes him a fantastic fit for us. Debasish has a real passion for problem solving and is an expert at understanding the nuances associated with a client need and then framing an optimal solution. We much look forward to working with and learning from him."
Prescient Healthcare Group is a specialty biopharmaceutical product strategy and decision support consultancy that helps our clients make better clinical and commercial decisions, resulting in improved outcomes for patients, customers and shareholders. With offices in London, New York, San Francisco, New Delhi and Beijing, we enhance the value of our clients' products, making sure they resonate with customers and stand out from the competition. Prescient comprises three specialist practices: InflexionRx provides highly valued decision support to competitive intelligence, strategic marketing, brand management, regulatory affairs, medical affairs, market access and regional teams from early clinical development to loss of exclusivity; VantageRx focuses on helping clients develop strategies that successfully differentiate their assets and brands at key milestones throughout new product planning, brand planning and mature brand planning; and FusionRx specializes in aligning cross-functional teams to ensure product strategies meet the needs of all customer types and robust execution plans are developed.